Abstract
Commercializing a diagnostic or life science product often encompasses different goals than that of research and grant funding. There are several necessary steps, and a strategy needs to be well defined in order to be successful. Product development requires input from and between various groups within a company and, for academia, outside entities. The product development stakeholder groups/entities are research, marketing, development, regulatory, manufacturing, clinical, safety/efficacy, and quality. After initial research and development, much of the work in product development can be outsourced or jointly created using public–private partnerships. This chapter serves as an overview of the product development process and provides a guide to best define a product strategy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lambert WJ (2010) Considerations in developing a target product profile for parenteral pharmaceutical products. AAPS PharmSciTech 11(3):1476–1481. doi:10.1208/s12249-010-9521-x
Rose LM, Everts M, Heller C, Burke C, Hafer N, Steele S (2014) Academic medical product development: an emerging alliance of technology transfer organizations and the CTSA. Clin Transl Sci 7(6):456–464. doi:10.1111/cts.12175
Bishai DM, Champion C, Steele ME, Thompson L (2011) Product development partnerships hit their stride: lessons from developing a meningitis vaccine for Africa. Health Aff (Millwood) 30(6):1058–1064. doi:10.1377/hlthaff.2011.0295
Mahoney RT (2011) Product development partnerships: case studies of a new mechanism for health technology innovation. Health Res Policy Syst 9:33. doi:10.1186/1478-4505-9-33
Wells WA, Brooks A (2011) Adoption of new health products in low and middle income settings: how product development partnerships can support country decision making. Health Res Policy Syst 9:15. doi:10.1186/1478-4505-9-15
Jahn R, Muller O, Bozorgmehr K (2015) Characteristics and determinants of knowledge transfer policies at universities and public institutions in medical research—protocol for a systematic review of the qualitative research literature. Syst Rev 4:110. doi:10.1186/s13643-015-0094-3
Jekunen A (2014) Decision-making in product portfolios of pharmaceutical research and development—managing streams of innovation in highly regulated markets. Drug Des Devel Ther 8:2009–2016. doi:10.2147/DDDT.S68579
Carroll MW (2015) Sharing research data and intellectual property law: a primer. PLoS Biol 13(8):e1002235. doi:10.1371/journal.pbio.1002235
Pramod K, Tahir MA, Charoo NA, Ansari SH, Ali J (2016) Pharmaceutical product development: a quality by design approach. Int J Pharm Investig 6(3):129–138. doi:10.4103/2230-973X.187350
Hakemeyer C, McKnight N, St John R, Meier S, Trexler-Schmidt M, Kelley B, Zettl F, Puskeiler R, Kleinjans A, Lim F, Wurth C (2016) Process characterization and design space definition. Biologicals 44(5):306–318. doi:10.1016/j.biologicals.2016.06.004
Ohage E, Iverson R, Krummen L, Taticek R, Vega M (2016) QbD implementation and Post Approval Lifecycle Management (PALM). Biologicals 44(5):332–340. doi:10.1016/j.biologicals.2016.06.007
Jain A, Taghavian O, Vallejo D, Dotsey E, Schwartz D, Bell FG, Greef C, Davies DH, Grudzien J, Lee AP, Felgner PL, Liang L (2016) Evaluation of quantum dot immunofluorescence and a digital CMOS imaging system as an alternative to conventional organic fluorescence dyes and laser scanning for quantifying protein microarrays. Proteomics 16(8):1271–1279. doi:10.1002/pmic.201500375
Gascon P, Fuhr U, Sorgel F, Kinzig-Schippers M, Makhson A, Balser S, Einmahl S, Muenzberg M (2010) Development of a new G-CSF product based on biosimilarity assessment. Ann Oncol 21(7):1419–1429. doi:10.1093/annonc/mdp574
Thomas JA, Collins CR, Das S, Hackett F, Graindorge A, Bell D, Deu E, Blackman MJ (2016) Development and application of a simple plaque assay for the human malaria parasite plasmodium falciparum. PLoS One 11(6):e0157873. doi:10.1371/journal.pone.0157873
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Alonso, M.M. (2017). Product Development and Commercialization of Diagnostic or Life Science Products for Scientists and Researchers. In: Espina, V. (eds) Molecular Profiling. Methods in Molecular Biology, vol 1606. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6990-6_26
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6990-6_26
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6989-0
Online ISBN: 978-1-4939-6990-6
eBook Packages: Springer Protocols